CANF vs CMMB: Side-by-Side Comparison
Compare Can-Fite Biopharma Ltd (CANF) and Chemomab Therapeutics Ltd (CMMB) side by side: market cap USD 5.12M vs USD 16.34M. Financials, growth and model signals on Bullrun.
| Metric | CANF | CMMB |
|---|---|---|
| Company | Can-Fite Biopharma Ltd | Chemomab Therapeutics Ltd |
| Country / Exchange | Israel · NYSE MKT | Israel · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 5.12M | USD 16.34M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | USD 405.00K | — |
| Revenue growth YoY | -39.9% | — |
| Net income | USD -9.83M | USD -9.00M |
| Gross margin | — | — |
| Diluted EPS | -5.97 | 0.02 |